Literature DB >> 17587821

Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity.

Jiri Zavadil1, Manisha Narasimhan, Miroslav Blumenberg, Robert J Schneider.   

Abstract

Noncoding microRNAs act as posttranscriptional repressors of gene function and are often deregulated in cancers and other diseases. Here we review recent findings on microRNA roles in tumorigenesis and report a microRNA profiling screen in transforming growth factor-beta1 (TGF-beta)-induced epithelial-mesenchymal transition (EMT) in human keratinocytes, a model of epithelial cell plasticity underlying epidermal injury and skin carcinogenesis. We describe a novel EMT-specific microRNA signature that includes induction of miR-21, a candidate oncogenic microRNA associated with carcinogenesis. By integrating the microRNA screen results with target prediction algorithms and gene expression profiling data, we outline a framework for TGF-beta-directed microRNA:messenger RNA (mRNA) regulatory circuitry and discuss its biological relevance for tumor progression. 2007 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17587821     DOI: 10.1159/000101316

Source DB:  PubMed          Journal:  Cells Tissues Organs        ISSN: 1422-6405            Impact factor:   2.481


  68 in total

Review 1.  Shielding the messenger (RNA): microRNA-based anticancer therapies.

Authors:  Elena Sotillo; Andrei Thomas-Tikhonenko
Journal:  Pharmacol Ther       Date:  2011-04-14       Impact factor: 12.310

2.  Significance of epithelial growth factor in the epithelial-mesenchymal transition of human gallbladder cancer cells.

Authors:  Takamitsu Sasaki; Hiroki Kuniyasu; Yi Luo; Daisuke Kato; Satoshi Shinya; Kiyomu Fujii; Hitoshi Ohmori; Yuichi Yamashita
Journal:  Cancer Sci       Date:  2012-04-03       Impact factor: 6.716

3.  miR-21 and miR-31 converge on TIAM1 to regulate migration and invasion of colon carcinoma cells.

Authors:  Charisa L Cottonham; Satoshi Kaneko; Lan Xu
Journal:  J Biol Chem       Date:  2010-09-07       Impact factor: 5.157

Review 4.  microRNAs and EMT in mammary cells and breast cancer.

Authors:  Josephine A Wright; Jennifer K Richer; Gregory J Goodall
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-25       Impact factor: 2.673

5.  lincRNA HOTAIR as a novel promoter of cancer progression.

Authors:  Gregory Loewen; Ying Zhuo; Yan Zhuang; Janarthanan Jayawickramarajah; Bin Shan
Journal:  J Can Res Updates       Date:  2014-07

Review 6.  Biomarkers for epithelial-mesenchymal transitions.

Authors:  Michael Zeisberg; Eric G Neilson
Journal:  J Clin Invest       Date:  2009-06-01       Impact factor: 14.808

7.  MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1).

Authors:  Soken Tsuchiya; Takeshi Fujiwara; Fumiaki Sato; Yutaka Shimada; Eiji Tanaka; Yoshiharu Sakai; Kazuharu Shimizu; Gozoh Tsujimoto
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

8.  A new regulatory loop in cancer-cell invasion.

Authors:  Oscar H Ocaña; M Angela Nieto
Journal:  EMBO Rep       Date:  2008-05-16       Impact factor: 8.807

9.  Wild type N-ras displays anti-malignant properties, in part by downregulating decorin.

Authors:  Marta Benet; Robin Yates Dulman; Raffi Suzme; Eleazar Vega-Saenz de Miera; Martha E Vega; Thuy Nguyen; Jiri Zavadil; Angel Pellicer
Journal:  J Cell Physiol       Date:  2012-06       Impact factor: 6.384

10.  microRNA-21 promotes cardiac fibrosis and development of heart failure with preserved left ventricular ejection fraction by up-regulating Bcl-2.

Authors:  Shuguang Dong; Wenhan Ma; Bohan Hao; Fen Hu; Lianhua Yan; Xiaofei Yan; Ya Wang; Zhijian Chen; Zhaohui Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.